Developing Selective, Orally Bioavailable Integrin Inhibitors

Time: 9:15 am
day: Day Two

Details:

  • Building an integrin library around the RGD and MIDAS structural motifs
  • Improving physicochemical properties of integrin inhibitors – what to address to make an orally active drug
  • Integrated drug discovery

Speakers: